Researchers Boosted siRNA Concentration Through Filtration
A new method from the University of Pennsylvania could enable at-home therapeutic administration for patients.
Updated on Sept. 25, 2026 in Chemistry

Live Poll
Should medical researchers prioritize developing drug manufacturing methods that enable at-home patient self-administration?
University of Pennsylvania researchers developed a technique to increase siRNA concentration to 230 mg/mL, surpassing previous limits that prevented at-home treatment. The method utilizes combined membrane charging and oscillatory vibration to overcome heavy fouling during the filtration process.
Why it matters
High filtration fouling previously prevented reaching the 200 mg/mL threshold required for home-administered siRNA therapies. This breakthrough potentially expands clinical access to a broader range of therapeutic options for patients.
The researchers applied a fixed negative charge to 10 kDa cellulose membranes and utilized 22 Hz oscillatory vibration to achieve the final concentration. This approach successfully improved upon the 180 mg/mL result obtained by using negative membrane charging alone.
The players
University of Pennsylvania
This private Ivy League research university based in Philadelphia is a major hub for biomedical and chemical engineering advancements.
Eli Lilly
This major pharmaceutical corporation focuses on discovering and developing medicines to address unmet health needs.
Journal of Membrane Science
This peer-reviewed academic publication provides a platform for research related to membrane technology and materials science.
The details
By applying a base chemistry reaction to create a fixed negative charge on cellulose membranes, the team leveraged electrostatic repulsion to reduce fouling. A pressurized air piston was also used to apply oscillatory vibration along a single axis to the filtration unit to optimize output.
Timeline
September 2026: The research was presented at BioProcess International 2026 in Boston.
September 25, 2026: The core research findings were released.
The Big Picture
This study follows the rigorous technical documentation patterns established by the Journal of Membrane Science publication standards. The findings represent a significant shift in membrane engineering, potentially rendering legacy, high-fouling filtration methods obsolete for high-concentration drug manufacturing.
If these manufacturing process changes are successfully scaled, patients may soon gain access to therapeutic siRNA treatments that can be administered at home rather than in a clinical setting. This advancement could significantly lower the barrier to entry for patients requiring long-term, self-managed medical therapies.
The takeaway
Advancements in membrane filtration are essential for scaling the production of complex, high-concentration biological drugs. Researchers continue to refine these industrial processes to make sophisticated medical treatments more accessible and convenient for the average patient.
Further reading
Learn more about the latest research in the field on the Chemistry section page.
Source note: This article includes information reported by BioXconomy.
Live Poll
Should medical researchers prioritize developing drug manufacturing methods that enable at-home patient self-administration?






